| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,204 |
702 |
$70K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,071 |
676 |
$17K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
96 |
95 |
$8K |
| 87631 |
|
19 |
19 |
$791.58 |
| 87581 |
|
19 |
19 |
$52.64 |
| 87486 |
|
19 |
19 |
$52.64 |
| 87640 |
|
35 |
33 |
$39.48 |
| 87529 |
|
12 |
12 |
$26.32 |
| 87541 |
|
14 |
14 |
$26.32 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$13.16 |
| 87563 |
|
12 |
12 |
$13.16 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$13.16 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$13.16 |
| 87653 |
|
13 |
13 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
67 |
63 |
$0.00 |
| 87511 |
|
12 |
12 |
$0.00 |